Citation: Tk. Harden et al., Drug analysis based on signaling responses to G-protein-coupled receptors (Reprinted from Receptor-Based Drug Design, vol 89, pg 79-105, 1998), J RECEPT SI, 21(2-3), 2001, pp. 167-190
Citation: Er. Lazarowski et al., Interplay of constitutively released nucleotides, nucleotide metabolism, and activity of P2Y receptors, DRUG DEV R, 53(2-3), 2001, pp. 66-71
Authors:
Lazarowski, ER
Rochelle, LG
O'Neal, WK
Ribeiro, CMP
Grubb, BR
Zhang, V
Harden, TK
Boucher, RC
Citation: Er. Lazarowski et al., Cloning and functional characterization of two murine uridine nucleotide receptors reveal a potential target for correcting ion transport deficiency in cystic fibrosis gallbladder, J PHARM EXP, 297(1), 2001, pp. 43-49
Authors:
Kim, YC
Brown, SG
Harden, TK
Boyer, JL
Dubyak, G
King, BF
Burnstock, G
Jacobson, KA
Citation: Yc. Kim et al., Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X(1) receptors, J MED CHEM, 44(3), 2001, pp. 340-349
Authors:
Kim, HS
Barak, D
Harden, TK
Boyer, JL
Jacobson, KA
Citation: Hs. Kim et al., Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists ofthe P2Y(1) receptor: Structure-activity relationships and receptor docking, J MED CHEM, 44(19), 2001, pp. 3092-3108
Authors:
Cunningham, ML
Waldo, GL
Hollinger, S
Hepler, JR
Harden, TK
Citation: Ml. Cunningham et al., Protein kinase C phosphorylates RGS2 and modulates its capacity for negative regulation of G alpha(11) signaling, J BIOL CHEM, 276(8), 2001, pp. 5438-5444
Citation: Ae. Brinson et Tk. Harden, Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors - Ser-333 and Ser-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor, J BIOL CHEM, 276(15), 2001, pp. 11939-11948
Authors:
Qi, AD
Kennedy, C
Harden, TK
Nicholas, RA
Citation: Ad. Qi et al., Differential coupling of the human P2Y(11) receptor to phospholipase C andadenylyl cyclase, BR J PHARM, 132(1), 2001, pp. 318-326
Authors:
Kennedy, C
Qi, AD
Herold, CL
Harden, TK
Nicholas, RA
Citation: C. Kennedy et al., ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor, MOLEC PHARM, 57(5), 2000, pp. 926-931
Authors:
Boyer, JL
Delaney, SM
Villaneuva, D
Harden, TK
Citation: Jl. Boyer et al., A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates, MOLEC PHARM, 57(4), 2000, pp. 805-810
Authors:
Malmsjo, M
Hou, MY
Harden, TK
Pendergast, W
Pantev, E
Edvinsson, L
Erlinge, D
Citation: M. Malmsjo et al., Characterization of contractile P2 receptors in human coronary arteries byuse of the stable pyrimidines uridine 5 '-O-thiodiphosphate and uridine 5 '-O-3-thiotriphosphate, J PHARM EXP, 293(3), 2000, pp. 755-760
Authors:
Nandanan, E
Jang, SY
Moro, S
Kim, HO
Siddiqui, MA
Russ, P
Marquez, VE
Busson, R
Herdewijn, P
Harden, TK
Boyer, JL
Jacobson, KA
Citation: E. Nandanan et al., Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands, J MED CHEM, 43(5), 2000, pp. 829-842
Authors:
Kim, YC
Gallo-Rodriguez, C
Jang, SY
Nandanan, E
Adams, M
Harden, TK
Boyer, JL
Jacobson, KA
Citation: Yc. Kim et al., Acyclic analogues of deoxyadenosine 3 ',5 '-bisphosphates as P2Y(1) receptor antagonists, J MED CHEM, 43(4), 2000, pp. 746-755
Citation: Er. Lazarowski et al., Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations, J BIOL CHEM, 275(40), 2000, pp. 31061-31068
Authors:
Malmsjo, M
Adner, M
Harden, TK
Pendergast, W
Edvinsson, L
Erlinge, D
Citation: M. Malmsjo et al., The stable pyrimidines UDP beta S and UTP gamma S discriminate between theP2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery, BR J PHARM, 131(1), 2000, pp. 51-56
Authors:
Filtz, TM
Cunningham, ML
Stanig, KJ
Paterson, A
Harden, TK
Citation: Tm. Filtz et al., Phosphorylation by protein kinase C decreases catalytic activity of avian phospholipase C-beta, BIOCHEM J, 338, 1999, pp. 257-264
Authors:
Jacobson, KA
Hoffmann, C
Kim, YC
Camaioni, E
Nandanan, E
Jang, SY
Guo, DP
Ji, XD
von Kugelgen, I
Moro, S
Ziganshin, AU
Rychkov, A
King, BF
Brown, SG
Wildman, SS
Burnstock, G
Boyer, JL
Mohanram, A
Harden, TK
Citation: Ka. Jacobson et al., Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis, PROG BRAIN, 120, 1999, pp. 119-132
Citation: Ml. Cunningham et al., Protein kinase C-promoted inhibition of G alpha(11)-stimulated phospholipase C-beta activity, MOLEC PHARM, 56(2), 1999, pp. 265-271
Authors:
Nandanan, E
Camaioni, E
Jang, SY
Kim, YC
Cristalli, G
Herdewijn, P
Secrist, JA
Tiwari, KN
Mohanram, A
Harden, TK
Boyer, JL
Jacobson, KA
Citation: E. Nandanan et al., Structure-activity relationships of bisphosphate nucleotide derivatives asP2Y(1) receptor antagonists and partial agonists, J MED CHEM, 42(9), 1999, pp. 1625-1638
Citation: Cs. Myung et al., Role of isoprenoid lipids on the heterotrimeric G protein gamma subunit indetermining effector activation, J BIOL CHEM, 274(23), 1999, pp. 16595-16603
Authors:
Hoffmann, C
Moro, S
Nicholas, RA
Harden, TK
Jacobson, KA
Citation: C. Hoffmann et al., The role of amino acids in extracellular loops of the human P2Y(1) receptor in surface expression and activation processes, J BIOL CHEM, 274(21), 1999, pp. 14639-14647